Exelixis
EXEL
$21.12
Share price
0.62%
Change (1 day)
8.31%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Stock price history for Exelixis (EXEL)
Highest end of day price: $49.25 USD on 2000-07-26
Lowest end of day price: $1.29 USD on 2014-12-24
Stock price history of Exelixis from 2000 to 2024
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $152.67 | 0.85% | 🇺🇸 USA |
 Pfizer PFE | $28.82 | 1.55% | 🇺🇸 USA |
 Amgen AMGN | $319.04 | 2.45% | 🇺🇸 USA |
 Sanofi SNY | $49.01 | -0.99% | 🇫🇷 France |
 Merck MRK | $131.73 | 2.39% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $44.55 | -0.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $45.70 | 0.09% | 🇬🇧 UK |
 Curis CRIS | $13.00 | -17.14% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $15.00 | 0.00% | 🇺🇸 USA |